XBP1 and metabolic dysfunction-associated steatohepatitis: To explore the effect of FT@XBP1 treatment on the diversity of gut microbiota in NASH mice, the V3–V4 regions of the intestinal bacterial 16S rDNA genes from CD, FFC_24W, and FFC diet in combination with FT@XBP1 (120 mg/kg) treatment were sequenced using the next-generation sequencing.